NCT06123832

Study of the Clinical Benefits of Different Formulations of Amphotericin B

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 184 (estimated)
• Sponsor: Qianfoshan Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This project intends to carry out a multi-center retrospective observational real-world study to understand the current status of amphotericin B use by formulation type, compare the differences in safety and efficacy of each formulation in domestic clinical application, provide real-world evidence for clinical drug selection, and provide evidence-based evidence in support of rational clinical drug use.

Detailed description

The researchers selected patients with amphotericin B use records discharged from five tertiary hospitals across the country from January 1, 2020 to the present, extracted data according to the inclusion and exclusion criteria, and divided them into experimental and control groups, in order to understand the current status of amphotericin B use in each preparation type, compare the differences in the safety and efficacy of the various preparations in the domestic clinical application, and provide real-world evidence of the choice of clinical medication.

Conditions

• Efficacy
• Safety

Timeline

• Start date: 2023-09-01
• Primary completion: 2024-08-31
• Completion: 2024-12-31
• First posted: 2023-11-09
• Last updated: 2024-10-17

Locations

1 site across 1 country: China